Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/28/2010US20100273886 Formulations and methods for lyophilization and lyophilates provided thereby
10/28/2010US20100273884 Method for stable and controlled delivery of (-)-hydroxycitric acid
10/28/2010US20100273883 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
10/28/2010US20100273882 Use of adapalene gel or cream
10/28/2010US20100273881 Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation
10/28/2010US20100273880 Storage-stable aqueous composition comprising a magnesium compound and l-carnitine
10/28/2010US20100273879 Method For Producing Acylglycinates
10/28/2010US20100273878 Preventive or therapeutic drug for alzheimer-type dementia
10/28/2010US20100273877 Emulsified skin external preparations and cosmetics
10/28/2010US20100273876 antibacterial formulation comprising a dialkyl sulphosuccinate and a carbanilide antibacterial agent
10/28/2010US20100273873 Direct compressible dextrose
10/28/2010US20100273872 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
10/28/2010US20100273871 Anticancer tocopheryl succinate derivatives
10/28/2010US20100273870 Compositions and methods for treating demodex infestations
10/28/2010US20100273869 Anti-cancer tocotrienol analogues and associated methods
10/28/2010US20100273868 R-Zileuton for Use in Conditions Associated with Increased 5-Lipoxygenase and/or Leukotriene Activity (EG Asthma)
10/28/2010US20100273867 Therapy-enhancing glucan
10/28/2010US20100273866 Diagnosis and treatment of cancer: i
10/28/2010US20100273863 Modulation of Gene Expression Using Oligomers That Target Gene Regions Downstream of 3' Untranslated Regions
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273861 Mycobacterial peptide deformylase
10/28/2010US20100273860 MODULATION OF APOLIPOPROTEIN (a) EXPRESSION
10/28/2010US20100273859 Treatment and prevention of hiv infection
10/28/2010US20100273858 Compositions comprising stat5 sirna and methods of use thereof
10/28/2010US20100273857 Suppression of scn9a gene expression and/or function for the treatment of pain
10/28/2010US20100273856 Screening of micro-rna cluster inhibitor pools
10/28/2010US20100273855 Compositions and methods of treating cancer
10/28/2010US20100273854 Compositions and methods for inhibiting nadph oxidase expression
10/28/2010US20100273853 Novel isoindol derivatives as ep4 receptor agonists
10/28/2010US20100273852 Pharmaceutical composition
10/28/2010US20100273851 Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
10/28/2010US20100273850 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273848 Iminopyrrolidone thiol amino acid conjugates, pharmaceutical compositions and methods for the treatment of cancer
10/28/2010US20100273847 Desferrioxamine conjugates, derivatives and analogues
10/28/2010US20100273846 Method for treating proliferative disorders associated with mutations in c-met
10/28/2010US20100273845 Angiotensin ii receptor antagonists
10/28/2010US20100273844 Pharmaceutical compositions for treating or preventing migaines
10/28/2010US20100273843 Heterocyclic self-immolative linkers and conjugates
10/28/2010US20100273842 Amine derivatives having npy y5 receptor antagonistic activity and the uses thereof
10/28/2010US20100273841 Amine-derivatives having npy y5 receptor antagonistic activity and the uses thereof
10/28/2010US20100273840 Water-soluble polymer-based cantharimides as potentially selective anti-tumor agents
10/28/2010US20100273839 Compounds Having Activity in Correcting Mutant-CFTR Processing and Uses Thereof
10/28/2010US20100273838 Stable topical compositions for 1,2,4-thiadiazole derivatives
10/28/2010US20100273837 Antibacterial agents
10/28/2010US20100273835 Novel compounds
10/28/2010US20100273834 Treatment of onychomycosis and related compositions including urea
10/28/2010US20100273833 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
10/28/2010US20100273831 Fluoro alkyl substituted benzimidazole cannabinoid agonists
10/28/2010US20100273829 Methods for Treating Disorders Associated with Hyperlipidemia in a Mammal
10/28/2010US20100273828 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
10/28/2010US20100273827 OXADIAZOLE DERIVATIVES ACTIVE ON SPHINGOSINE-1-PHOSPHATE (S1p)
10/28/2010US20100273826 Methods of use and compositions for the diagnosis and treatment of infectious diseases
10/28/2010US20100273825 Solid pharmaceutical composition containing solifenacin amorphous form
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273822 Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins
10/28/2010US20100273821 Methods and compositions for treating dry eye
10/28/2010US20100273820 Peripheral Phenolic Opioid Antagonist
10/28/2010US20100273819 3,3'-Spiroindolinone Derivatives
10/28/2010US20100273818 Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
10/28/2010US20100273817 Anti-cancer cyclopenta(g)quinazoline compounds
10/28/2010US20100273816 Quinazoline Compounds
10/28/2010US20100273814 ((phenyl)imidazolyl)methylheteroaryl compounds
10/28/2010US20100273813 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
10/28/2010US20100273812 Diazo bicyclic smac mimetics and the uses thereof
10/28/2010US20100273811 N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and Salts Thereof
10/28/2010US20100273810 Method of treating cognitive impairments and schizophrenias
10/28/2010US20100273809 Method and composition for treating an alpha adrenoceptor-mediated condition
10/28/2010US20100273808 Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
10/28/2010US20100273807 Use of PDE III Inhibitors for the Treatment of Asymptomatic (Occult) Heart Failure
10/28/2010US20100273806 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
10/28/2010US20100273805 Sulphide bridged derivatives as modulators of mglur5 733
10/28/2010US20100273804 Pyridazine derivatives useful as fungicides and for the treatment of cancer
10/28/2010US20100273803 Oral Formulations for Tetrapyrrole Derivatives
10/28/2010US20100273802 New purine derivatives having, in particular, anti-proliferative properties, and their biological uses
10/28/2010US20100273801 Betulin derived compounds useful as antibacterial agents
10/28/2010US20100273800 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
10/28/2010US20100273799 Small molecule inhibitors of mdm2 and the uses thereof
10/28/2010US20100273798 Processes for the preparation of rivaroxaban and intermediates thereof
10/28/2010US20100273797 Alpha-ketoamides and derivatives thereof
10/28/2010US20100273796 2-benzylpyridazinone derivatives as met kinase inhibitors
10/28/2010US20100273795 Arylsulfonamide ccr3 antagonists
10/28/2010US20100273794 Benzimidazolone Compounds Having 5-HT4 Receptor Agonistic Activity
10/28/2010US20100273793 6-ARYL/HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS c-MET INHIBITORS
10/28/2010US20100273792 Macrocyclic indoles as hepatitis c virus inhibitors
10/28/2010US20100273791 Tricyclic pyrazole derivatives as cannabinoid receptor modulators
10/28/2010US20100273790 Processes for the preparation of rivaroxaban and intermediates thereof
10/28/2010US20100273789 Aminoacyl prodrugs
10/28/2010US20100273788 Fused heterocyclic derivative and use thereof
10/28/2010US20100273787 Kynurenine-aminotransferase inhibitors
10/28/2010US20100273786 Tetrahydro-imidaz0[1,5-a]pyrazine derivatives, preparation process and medicinal use thereof
10/28/2010US20100273785 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273784 Fused ring heterocycles as potassium channel modulators
10/28/2010US20100273783 Compositions and Methods for Treating and Preventing Overactive Bladder and Conditions Associated Therewith
10/28/2010US20100273782 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273781 Cxcr3 receptor antagonists
10/28/2010US20100273780 Substituted 8-heteroaryl xanthines
10/28/2010US20100273779 Pyridazinone Derivatives
10/28/2010US20100273778 Treatment of osteoarthritis pain
10/28/2010US20100273777 Compounds for Modulating TRPV3 Function
1 ... 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 ... 7860